Clinical trial · Observational
Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.
A Multicenter, Observational Study for the Clinical Roadmap and Prognosis of Pulmonary Artery Sarcoma.
NCT06165718CI-TRIAL-00072300unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is an observational study in which patients with pulmonary artery sarcoma were followed up for at least 36 months and survival was investigated.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pulmonary Artery Sarcoma | Pulmonary Artery Intimal Sarcoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Progression-free survival
- timeFrame
- 36 months
- description
- Time to death or disease progression
Secondary outcomes (2)
- measure
- Overall survival
- timeFrame
- 36 months
- description
- Time to death
- measure
- Postoperative survival
- timeFrame
- 36 months
- description
- Time from surgery to death
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Computed tomography pulmonary angiography indicated that there were intraluminal defects * Malignant histopathology was sarcoma * Informed consent form was signed Exclusion Criteria: * Life expectancy was less than 3 months due to diseases other than pulmonary artery sarcoma * Expected inability to complete follow-up
References
Publications (0)
Data not yet available
No reference posted for this study.